Large size fibrillar bundles of the Alzheimer amyloid β-protein

European Biophysics Journal

Volumn 36, Issue 7, 2007, Pages 701-709

  Carrotta, Rita ^a   Barthès, Jennifer ^b   Longo, Alessandro ^c   Martorana, Vincenzo ^b   Manno, Mauro ^b   Portale, Giuseppe ^d   San Biagio, Pier Luigi ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR   (Italy)

^c CNR   (Italy)

^d EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

Author keywords

Alzheimer; Amyloid fibrils; Light scattering; Plaques; X ray scattering

Indexed keywords

AMYLOID BETA PROTEIN;

CONFERENCE PAPER; IN VITRO STUDY; LIGHT SCATTERING; PHASE CONTRAST MICROSCOPY; PROTEIN AGGREGATION; X RAY CRYSTALLOGRAPHY;

AMYLOID; AMYLOID BETA-PROTEIN; LIGHT; PEPTIDE FRAGMENTS; SCATTERING, SMALL ANGLE; X-RAY DIFFRACTION;

EID: 36048943585     PISSN: 01757571     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00249-007-0164-0     Document Type: Conference Paper

References (38)

1. Ban T, Hoshino M, Takahashi S, Hamada D, Hasegawa K, Naiki H, Goto Y (2004) Direct observation of Aβ amyloid fibril growth and inhibition. J Mol Biol 344:757-767
2. Berne BJ, Pecora R (1976) Dynamic light scattering. Wiley Interscience, New York
3. Borsboom M, Bras W, Cerjak I, Detollenaere D, Glastra van Loon D, Goedtkindt P, Konijnenburg M, Lassing P, Levine YK, Munneke B, Oversluizen M, van Tol R, Vlieg E (1998) The dutch-belgian beamline at the esrf. J Synchroton Rad 5:518-520
4. Bras W (1998) A saxs/waxs beamline at the esrf and future experiments. J Macromol Sci Phys B 37:557-566
5. Bulone D, Giacomazza D, Martorana V, Newman J, San Biagio PL (2004) Ordering of agarose near the macroscopic gelation point. Phys Rev E 69:0411401-1-0411401-9
6. Carrotta R, Manno M, Bulone D, Martorana V, San Biagio PL (2005) Protofibril formation of amyloid β-protein at low pH via a non-cooperative elongation mechanism. J Biol Chem 280:30001-30008
7. Carrotta R, Di Carlo M, Manno M, Montana G, Picone P, Romancino D, San Biagio PL (2006) Toxicity of recombinant β-amyloid prefibrillar oligomers on the morphogenesis of the sea urchin paracentrotus lividus. FASEB J 20:1916-1917
8. Ferri F, Magatti D, Pescini D, Potenza MAC, Giglio M (2004) Heterodyne near-field scattering: a technique for complex fluids. Phys Rev E 70:041405-1-041405-9
9. Georganopoulou DG, Chang L, Nam J-W, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA (2005) Nanoparticle-based detection in cerebral spinal Fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci (USA) 102:2273-2276
10. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890
11. Hammersley AP (1997) Fit2d: an introduction and overview. ESRF Internal Report ESRF97HA02T Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356
12. Harper JD, Wong SS, Lieber CM, Lansbury PTJ (1997) Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem Biol 4:119-125
13. Hoshi M, Sato M, Matsumoto S, Noguchi A, Yasutake K, Yoshida N, Sato K (2003) Spherical aggregates of b-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β. Proc Natl Acad Sci USA 100:6370-6375
14. Huang THJ, Yang DS, Plaskos NP, Go S, Yip CM, Fraser PE, Chakrabartty A (2000) Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide. J Mol Biol 297:73-87
15. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ 42(43). Neuron 13:45-53
16. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL,Wals P, Zhang C, Finch CE, Krafft GA (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453
17. Lansbury PTJ (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci USA 96:3342-3344
18. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PTJ (2002) Amyloid pores from pathogenic mutations. Nature 418:291-291
19. Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB (1996) On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci USA 93:1125-1129
20. Manno M, Craparo EF, Martorana V, Bulone D, San Biagio PL (2006) Kinetics of insulin aggregation: disentanglement of amyloid fibrillation from large-size cluster formation. Biophys J 90:4585-4591
21. Manno M, Craparo EF, Podest_a A, Bulone D, Carrotta R, Martorana V, Tiana G, San Biagio PL (2007) Kinetics of different processes in human insulin amyloid formation. J Mol Biol 366:258-274
22. Mathis CA, Klunk WE, Price JC, DeKosky ST (2005) Imaging technology for neurodegenerative diseases. Arch Neurol 62:196-200
23. Muller-Hill B, Beyreuther K (1989) Molecular biology of Alzheimer's disease. Ann Rev Biochem 58:287-307
24. Nicolai T, Durand D, Gimel J-C (1996) In: Light scattering: Principles, development. In: W Brown (eds) Scattering properties and modeling of aggregating and gelling systems. Clarendon Press, Oxford, pp 201-231
25. Pedersen JS (1993) Small-angle scattering from precipitates: analysis by use of a polydisperse hard-sphere model. Phys Rev B 47:657-665
26. Pedersen JS (1997) Analysis of small-angle scattering data from colloids and polymer solutions: modelling and least-squares fitting. Adv Colloid Interface Sci 70:171-210
27. Pitschke M, Prior R, Haupt M, Riesner D (1998) Detection of single amyloid b-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy. Nat Med 4:832-834
28. Rensink AAM, de Waal RMW, Kremer B, Verbeek MM (2003) Pathology of cerebral amyloid angiopathy. Brain Res Rev 43:207-223
29. Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A23-A31
30. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791
31. Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR (2006) Pet of brain amyloid and tau in mild cognitive impairment. New Engl J Med 355:2652-2663
32. Stepanek P (1993) In: Dynamic light scattering: The method, some application. In: Brown W (eds) Ch. Data analysis in dynamic light scattering. Clarendon Press, Oxford, pp 177-240
33. Temussi PA, Masino L, Pastore A (2003) From Alzheimer to Huntington: why is a structural understanding so difficult? EMBO J 22:355-361
34. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580
35. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB (1997) Amyloid β-protein fibrillogenesis: detection of a protofibrillar intermediate. J Biol Chem 272:22364-22372
36. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539
37. Westlind-Danielsson A, Arnerup G (2001) Spontaneous in vitro formation of supramolecular β-amyloid structures, "βamy balls", by β-amyloid 1-40 peptide. Biochemistry 40:14736-14743
38. Yong W, Lomakin A, Kirkitadze MD, Teplow DB, Chen S-H, Benedek GB (2002) Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly using small angle neutron scattering. Proc Natl Acad Sci USA 99:150-154